ArticleHealth science reports2025
Can "Attenuation Subtraction", a Computed Tomography Scan-Based Factor, be Used as a Predictor of High-Risk Esophageal Varices in Cirrhotic Patients? A Retrospective Cohort Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Liver cirrhosis is a severe condition that can result in complications such as portal hypertension and esophageal varices (EVs). While current guidelines recommend screening for EVs, existing procedures are often invasive, costly, and occasionally unreliable. This study aims to develop a CT-based predictor for identifying high-risk esophageal varices group (HRG) in cirrhotic patients, offering a noninvasive, safe, and cost-effective alternative that integrates seamlessly into routine follow-up without requiring additional resources or time. Methods: The study retrospectively analyzed data from 2016 to 2021 of cirrhotic patients referred to a hospital in Tehran. Experienced professionals analyzed factors related to CT scans, and patients were categorized into high-risk and non-high-risk varicose veins groups by endoscopy. The main sample size for the study was 62 patients with an average age of 50.2 ± 11.5 years. Also, we aimed to determine a diagnostic cutoff and externally validated it in a separate statistical population (29 patients). Result: The study found that liver attenuation subtraction, Child-Pugh score, and direct visualization of esophageal varices in CT scans were significant factors in predicting high-risk esophageal varices. The study showed that a liver attenuation subtraction of 14.5 HU (CI 95%: 0.949-1) with an inverse relationship could predict high-risk esophageal varices with high accuracy. Conclusion: The study indicated that liver "Attenuation Subtraction" in CT scans distinguishes high-risk and non-high-risk esophageal varices. Furthermore, external validation demonstrated that this cutoff value is generalizable to other statistical populations. We pinpoint an indicator of high-risk esophageal varices in patients with cirrhosis devoid of invasiveness and peril and do not impose supplementary expenses or time beyond the customary monitoring of cirrhotic patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.